Top Biopharmaceutical Companies in China

Evive Biotech is a global biopharmaceutical company focused on developing innovative biological therapies, particularly in oncology, inflammatory, and metabolic diseases. With a strong pipeline of drug candidates and a commitment to addressing unmet medical needs, the company leverages advanced research and manufacturing capabilities to bring novel treatments to market.

Bioworkshops is a specialized biologics contract development and manufacturing organization (CDMO) with extensive experience in providing CMC services for late-stage clinical products. Their focus on regulatory affairs and commitment to international GMP compliance supports the rapid approval and market entry of biologic products.

Biotheus is dedicated to the discovery and development of novel biopharmaceuticals, particularly targeting cancer and inflammatory diseases. With a pipeline of over 20 products, several are currently in clinical trials in China.

The company provides a platform that connects users with over 8,000 high-quality suppliers and 3.6 million pharmaceutical products, offering insights into the global pharmaceutical industry.

The company, BRIM Biotechnology, focuses on developing innovative biopharmaceuticals that aim to cure diseases and improve patient lives, emphasizing affordability and accessibility. Their expertise in translational science has led to the advancement of several drug discoveries, including a first-in-class treatment for Dry Eye Disease.

Biointron is a prominent provider of high-throughput recombinant antibody and protein expression services, having delivered tens of thousands of recombinant antibodies to over 1,500 biotech and pharma companies globally. Their commitment to advancing biotechnology through innovative research and development aligns with the broader goals of the biopharmaceutical industry to improve human health.

The company specializes in providing integrated engineering solutions for pharmaceutical and medical factories, ensuring compliance with international GMP standards. They are currently constructing a Soft Bag IV-Solution Pharmaceutical Factory in Nigeria, capable of producing 20 million soft bags annually, highlighting their expertise in the biopharmaceutical sector.

BioDuro-Sundia is a prominent contract research, development, and manufacturing organization (CRDMO) with over 28 years of experience, specializing in both small and large molecule discovery, development, scale-up, and manufacturing. They leverage unique technology platforms to support biotech and pharmaceutical partners, offering fully integrated services that accelerate development timelines.

LP Pharma is dedicated to advancing biopharmaceutical solutions through innovative formulation platforms that enhance drug delivery across various therapeutic areas. Their focus on developing options such as oral films and controlled release doses underscores their commitment to improving therapeutic efficacy.

Hipro Biotechnology Corp is a leading specialist in the development and manufacturing of high-quality diagnostic system solutions, emphasizing innovation in accurate diagnostic systems, including instrumentation and reagents. Their focus on R&D and point-of-care products positions them as a key player in the biopharmaceutical landscape.